Magnetocardiography

Ventricular arrhythmias

R. Fenici, G. Melillo

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Since 1985, magnetocardiographic (MCG) mapping has been carried out in patients with severe ventricular arrhythmias, related to primary cardiomyopathy and ischaemic heart disease, for the purpose of non-invasive localization of the arrhythmogenic substrate or to screen patients at risk of sudden death. Data reported by several authors have demonstrated that magnetocardiography is useful to investigate non-invasively some of the possible electrogenetic abnormalities underlying clinical arrhythmias and to identify patients at risk of sudden death through the detection of late magnetic fields and quantitative estimation of repolarization/depolarization abnormalities. In this paper all the above-mentioned applications have been briefly reviewed. Experience based on 35 patients, with Lown class 3 or higher ventricular arrhythmias, who have been studied magnetically, to localize the site of origin of their ventricular arrhythmia and to calculate their Relative Smoothness Index is described. Reproducible MCG three-dimensional localization of both ventricular extrasystoles and sustained tachycardia proved possible, using even single channel instrumentation, with an accuracy in the order of 10 mm as demonstrated by inverse localization of a biomagnetic catheter. The RS index was significantly lower in patients with cardiomyopathy or sudden death, but this parameter needs further investigation, as methodological drawbacks could impair its clinical reliability. In conclusion, MCG localization of the arrhythmogenic substrate can be useful to guide aimed invasive electrophysiology, biopsy and ablation close to-the arrhythmogenic substrate.

Original languageEnglish
Pages (from-to)53-60
Number of pages8
JournalEuropean Heart Journal
Volume14
Issue numberSUPPL. E
Publication statusPublished - 1993

Fingerprint

Magnetocardiography
Cardiac Arrhythmias
Sudden Death
Cardiomyopathies
Ventricular Premature Complexes
Electrophysiology
Magnetic Fields
Tachycardia
Myocardial Ischemia
Catheters
Biopsy

Keywords

  • Catheter ablation
  • Magnetocardiography
  • Ventricular tachycardia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Magnetocardiography : Ventricular arrhythmias. / Fenici, R.; Melillo, G.

In: European Heart Journal, Vol. 14, No. SUPPL. E, 1993, p. 53-60.

Research output: Contribution to journalArticle

Fenici, R & Melillo, G 1993, 'Magnetocardiography: Ventricular arrhythmias', European Heart Journal, vol. 14, no. SUPPL. E, pp. 53-60.
Fenici, R. ; Melillo, G. / Magnetocardiography : Ventricular arrhythmias. In: European Heart Journal. 1993 ; Vol. 14, No. SUPPL. E. pp. 53-60.
@article{9cfe725e17a64cafb0e93bafc6cbc283,
title = "Magnetocardiography: Ventricular arrhythmias",
abstract = "Since 1985, magnetocardiographic (MCG) mapping has been carried out in patients with severe ventricular arrhythmias, related to primary cardiomyopathy and ischaemic heart disease, for the purpose of non-invasive localization of the arrhythmogenic substrate or to screen patients at risk of sudden death. Data reported by several authors have demonstrated that magnetocardiography is useful to investigate non-invasively some of the possible electrogenetic abnormalities underlying clinical arrhythmias and to identify patients at risk of sudden death through the detection of late magnetic fields and quantitative estimation of repolarization/depolarization abnormalities. In this paper all the above-mentioned applications have been briefly reviewed. Experience based on 35 patients, with Lown class 3 or higher ventricular arrhythmias, who have been studied magnetically, to localize the site of origin of their ventricular arrhythmia and to calculate their Relative Smoothness Index is described. Reproducible MCG three-dimensional localization of both ventricular extrasystoles and sustained tachycardia proved possible, using even single channel instrumentation, with an accuracy in the order of 10 mm as demonstrated by inverse localization of a biomagnetic catheter. The RS index was significantly lower in patients with cardiomyopathy or sudden death, but this parameter needs further investigation, as methodological drawbacks could impair its clinical reliability. In conclusion, MCG localization of the arrhythmogenic substrate can be useful to guide aimed invasive electrophysiology, biopsy and ablation close to-the arrhythmogenic substrate.",
keywords = "Catheter ablation, Magnetocardiography, Ventricular tachycardia",
author = "R. Fenici and G. Melillo",
year = "1993",
language = "English",
volume = "14",
pages = "53--60",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "SUPPL. E",

}

TY - JOUR

T1 - Magnetocardiography

T2 - Ventricular arrhythmias

AU - Fenici, R.

AU - Melillo, G.

PY - 1993

Y1 - 1993

N2 - Since 1985, magnetocardiographic (MCG) mapping has been carried out in patients with severe ventricular arrhythmias, related to primary cardiomyopathy and ischaemic heart disease, for the purpose of non-invasive localization of the arrhythmogenic substrate or to screen patients at risk of sudden death. Data reported by several authors have demonstrated that magnetocardiography is useful to investigate non-invasively some of the possible electrogenetic abnormalities underlying clinical arrhythmias and to identify patients at risk of sudden death through the detection of late magnetic fields and quantitative estimation of repolarization/depolarization abnormalities. In this paper all the above-mentioned applications have been briefly reviewed. Experience based on 35 patients, with Lown class 3 or higher ventricular arrhythmias, who have been studied magnetically, to localize the site of origin of their ventricular arrhythmia and to calculate their Relative Smoothness Index is described. Reproducible MCG three-dimensional localization of both ventricular extrasystoles and sustained tachycardia proved possible, using even single channel instrumentation, with an accuracy in the order of 10 mm as demonstrated by inverse localization of a biomagnetic catheter. The RS index was significantly lower in patients with cardiomyopathy or sudden death, but this parameter needs further investigation, as methodological drawbacks could impair its clinical reliability. In conclusion, MCG localization of the arrhythmogenic substrate can be useful to guide aimed invasive electrophysiology, biopsy and ablation close to-the arrhythmogenic substrate.

AB - Since 1985, magnetocardiographic (MCG) mapping has been carried out in patients with severe ventricular arrhythmias, related to primary cardiomyopathy and ischaemic heart disease, for the purpose of non-invasive localization of the arrhythmogenic substrate or to screen patients at risk of sudden death. Data reported by several authors have demonstrated that magnetocardiography is useful to investigate non-invasively some of the possible electrogenetic abnormalities underlying clinical arrhythmias and to identify patients at risk of sudden death through the detection of late magnetic fields and quantitative estimation of repolarization/depolarization abnormalities. In this paper all the above-mentioned applications have been briefly reviewed. Experience based on 35 patients, with Lown class 3 or higher ventricular arrhythmias, who have been studied magnetically, to localize the site of origin of their ventricular arrhythmia and to calculate their Relative Smoothness Index is described. Reproducible MCG three-dimensional localization of both ventricular extrasystoles and sustained tachycardia proved possible, using even single channel instrumentation, with an accuracy in the order of 10 mm as demonstrated by inverse localization of a biomagnetic catheter. The RS index was significantly lower in patients with cardiomyopathy or sudden death, but this parameter needs further investigation, as methodological drawbacks could impair its clinical reliability. In conclusion, MCG localization of the arrhythmogenic substrate can be useful to guide aimed invasive electrophysiology, biopsy and ablation close to-the arrhythmogenic substrate.

KW - Catheter ablation

KW - Magnetocardiography

KW - Ventricular tachycardia

UR - http://www.scopus.com/inward/record.url?scp=0027375435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027375435&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 53

EP - 60

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - SUPPL. E

ER -